Recombinant Human Type III Collagen, CAS No.9007-34-5

CAS: 9007-34-5 Cat. No.: rp336826 Número EC: 232-697-4

GRADE & PURITY Animal Free, Carrier Free, Recombinant, ≥95%(SEC-HPLC)

Expression system

Pichia pastoris

Endotoxin Concentration

<0.5 EU/μg

Descripción general

Recombinant type III humanized collagen is produced via safe and reliable yeast fermentation and bioenzymatic hydrolysis technologies. It is free of viral risks and has low immunogenicity, featuring higher safety, higher purity, and a shorter production cycle. In terms of applications, recombinant type III humanized collagen, with its high biological activity and excellent biocompatibility, is widely used in fields such as biomedical dressings, wound repair materials, tissue engineering scaffolds, mucosal repair preparations, and medical device coatings. It can accelerate wound healing, repair damaged tissues, and restore barrier function. Meanwhile, it can also serve as a bioactive additive in functional care products to relieve discomfort, repair fragile barriers, and improve tissue health. It is a core biological material of great value in the fields of biomedicine and healthcare. 

Specifications

Product Name

Recombinant Human Type III Collagen, CAS No.9007-34-5

Grado

Animal Free, Carrier Free, Recombinant

Especificaciones y pureza

Animal Free, Carrier Free, Recombinant, ≥95%(SEC-HPLC)

Mecanismos bioquímicos y fisiológicos

Collagen type III occurs in most soft connective tissues along with type I collagen. Involved in regulation of cortical development. Is the major ligand of ADGRG1 in the developing brain and binding to ADGRG1 inhibits neuronal migration and activates the

Concentración de endotoxinas

<0.5 EU/μg

Peso molecular previsto

45.6-55.6 kDa

CAS

9007-34-5

Tipo de molécula

Protein

Almacenamiento y envío

Reconstitución

Reconstitute in sterile water or physiological saline.

Condiciones de almacenamiento de almacenamiento

Store at 2-8°C

Enviado en

Wet ice

Estabilidad y almacenamiento

Store at 2~8℃ long term (24 months). Upon reconstitution, it is recommended to aliquot. Avoid freeze/thaw cycle. Store in the dark. Desiccated.

Referencias

1. Yufeng Dai, Jinxiang Chen, Jialong Fang, Shuxiao Liang, Hao Zhang, Haitao Li, Wei Chen.  (2024)  Ginkgolide B alleviates glucolipid metabolism disorders and adipose tissue inflammation by inhibiting thromboxane A2 synthesis.  Food Bioscience,      [PMID:] [10.1016/j.fbio.2024.103807]

2. Junjie Li, Yixu Wang, Jiawei Li, Sihan Xu, Shou Wang, Wenjuan Liu, Li Fu, Min Jiang, Gang Bai.  (2024)  Phillyrin and its metabolites treat pulmonary embolism by targeting PLCβ3 to inhibit platelet activation.  JOURNAL OF ETHNOPHARMACOLOGY,      [PMID:38866117] [10.1016/j.jep.2024.118457]

3. Yufeng Dai, Jinxiang Chen, Jialong Fang, Shuxiao Liang, Hao Zhang, Haitao Li, Wei Chen.  (2024)  Piperlongumine, a natural alkaloid from Piper longum L. ameliorates metabolic-associated fatty liver disease by antagonizing the thromboxane A2 receptor.  BIOCHEMICAL PHARMACOLOGY,      [PMID:39236933] [10.1016/j.bcp.2024.116518]

4. Yu Han, Xiufeng Jia, Yinwei Yang, Pei Guo, Chao Li, Yunze Zhang, Li Yin, Bo Jia, Haitao Wang.  (2025)  Study of bioactive 3D-printed scaffolds incorporating zinc-based MOF for bone defect repair and anti-inflammatory applications.  Materials Today Bio,      [PMID:40510838] [10.1016/j.mtbio.2025.101884]

5. Yunxia Du, Di Xiao, Changle Ren, Zhenlan Li, Xiaofeng Wang, Yantao Zhao, Yongmei Jiang.  (2026)  pH-responsive polydopamine-shelled 3D-printed chitosan/collagen hydrogel integrating exosomes and an enzyme/peptide cascade for diabetic wound healing.  Biomaterials Science,      [PMID:41685930] [10.1039/D5BM01823D]

6. Zhonghao Li, Zhihan Cai, Tao Zhu, Chaoyang Gong.  (2026)  Visualization of Protein Network Mechanical Heterogeneity Using Ultrasound-Coupled Microcavity Lasers.  Laser & Photonics Reviews,      [PMID:] [10.1002/lpor.202502742]